Clinical trial guidance for antibiotic drugs

21 U.S. Code § 360a. Clinical trial guidance for antibiotic drugs

(a) In general
Not later than 1 year after September 27, 2007, the Secretary shall issue guidance for the conduct of clinical trials with respect to antibiotic drugs, including antimicrobials to treat acute bacterial sinusitis, acute bacterial otitis media, and acute bacterial exacerbation of chronic bronchitis. Such guidance shall indicate the appropriate models and valid surrogate markers.
This document is only available to subscribers. Please log in or purchase access.